PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Life Sciences, Jilin University, Changchun, 130012, PR China.\', \'Faculty of Pharmacy, Shaanxi University of Science & Technology, Xi\'an, 710021, PR China.\', \'School of Life Sciences, Jilin University, Changchun, 130012, PR China; Faculty of Pharmacy, Shaanxi University of Science & Technology, Xi\'an, 710021, PR China. Electronic address: chengyuanliang@gmail.com.\', \'Shaanxi Panlong Pharmaceutical Group Co., Ltd., Xi\'an, 710025, PR China.\', \'School of Medicine and Pharmacy, Shaanxi University of Business & Commerce, Xi\'an 712046, PR China.\', \'Zhuhai Jinan Selenium Source Nanotechnology Co., Ltd., Hengqin New Area, Zhuhai, 519030, PR China. Electronic address: sesource_liuhong@163.com.\', \'Zhuhai Jinan Selenium Source Nanotechnology Co., Ltd., Hengqin New Area, Zhuhai, 519030, PR China. Electronic address: sesource_cwq@163.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0753-3322(21)00098-610.1016/j.biopha.2021.111313
?:doi
?:hasPublicationType
?:journal
  • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
is ?:pmid of
?:pmid
?:pmid
  • 33556871
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • An update review of emerging small-molecule therapeutic options for COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33556871>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33556871>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all